ClinicalTrials.Veeva

Menu

Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management

S

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status

Enrolling

Conditions

Hairy Cell Leukemia (HCL)

Study type

Observational

Funder types

Other

Identifiers

NCT06774677
HCL-EV
PNRR-TR1-2023-12377450 (Other Grant/Funding Number)

Details and patient eligibility

About

This is a national multi-centre, experimental, cross-sectional, non-profit study.

Full description

Extracellular vesicles are small particles circulating in plasma and documented as key players of intercellular crosstalk thanks to their cargo of proteins, lipids, and nucleic acids. The driving hypothesis of this study is that in Hairy Cell Leukemia-derived extracellular vesicles contribute to the maintenance of the tumor clone through regulation of selected key cells of the tumor microenvironment including immune cells and stromal cells, likely favoring immune evasion and marrow fibrosis. As a consequence, these circulating particles may be instrumental at identifying a biology-related, disease-specific and extracellular vesicle-based signature associated to outcomes.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria for patients:

  • WHO2022-defined diagnosis of Hairy Cell Leukemia.
  • Age ≥18 years.
  • Signed informed consent.

Inclusion criteria for Healthy Donors:

  • Age ≥18 years.
  • Volunteers in general good health, free from any disease or serious illness.
  • Signed informed consent.

Exclusion criteria

  • None

Trial contacts and locations

3

Loading...

Central trial contact

Lucia Catani, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems